Integration of HCV Treatment within an HIV Clinic
Resource from the RWHAP Best Practices Compilation updated on 05/15/2024
Resource from the RWHAP Best Practices Compilation updated on 05/15/2024
Resource updated 10/05/2023
Key dates for the HIVQM Module submission timeline.
Resource updated 09/14/2023
Resource updated 11/29/2023
Resource (Conference Presentation) updated 09/14/2023
Barriers and facilitators to HCV treatment during the DAA era for the understudied and high-risk population of HIV/HCV co-infected patients who delay or do not consent to treatment, and interventions for increasing DAA treatment uptake.
Resource (Conference Presentation) updated 09/14/2023
Overview of the policies, procedures, and protocols developed by an ADAP and Part C clinic to establish access to antiretrovirals, including long-acting cabotegravir/rilpivirine.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 09/19/2023
Resource updated 04/16/2024
Resource updated 09/19/2023
Resource updated 05/15/2024
Resource from the RWHAP Best Practices Compilation updated on 05/20/2024
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 05/15/2024
Resource updated 06/27/2024
Resource updated 10/10/2023
Resource updated 07/17/2024
Resource updated 06/27/2024
Resource updated 01/29/2024
Resource updated 04/12/2024